[Form 4] Krispy Kreme, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Krispy Kreme director Marissa Andrada received a significant equity grant on June 17, 2025, according to a Form 4 filing. The transaction details reveal:

• Acquisition of 47,795 restricted stock units (RSUs) at $0 cost
• RSUs will vest on June 17, 2028 (3-year vesting period)
• Upon vesting, RSUs convert to common stock on a one-for-one basis
• Following the transaction, Andrada's total beneficial ownership includes:
  • 4,140 shares held directly
  • 63,807 unvested RSUs

This equity grant appears to be part of director compensation and aligns the director's interests with shareholders through long-term vesting requirements. The transaction was reported within the required SEC filing deadline.

Positive

• Director Marissa Andrada received a significant equity grant of 47,795 RSUs worth approximately $716,925 (based on current market price), vesting in 2028, demonstrating long-term alignment with shareholder interests

Negative

• None.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Andrada Marissa

(Last) (First) (Middle)

C/O KRISPY KREME, INC.

2116 HAWKINS STREET

(Street)

CHARLOTTE NC 28203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Krispy Kreme, Inc. [ DNUT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		A		47,795(1)	A	$0	67,947(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of restricted stock units ("RSUs") that upon vesting are settled on a one-for-one basis in shares of common stock. Subject to certain terms and conditions, the RSUs will vest on June 17, 2028.

2. Direct: 4,140, unvested RSUs: 63,807.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Christine McDevitt, Attorney-in-fact	06/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many DNUT shares did Director Marissa Andrada acquire on June 17, 2025?

Director Marissa Andrada acquired 47,795 restricted stock units (RSUs) on June 17, 2025, which will be settled in common stock on a one-for-one basis upon vesting.

When will Marissa Andrada's DNUT RSUs vest?

The RSUs granted to Marissa Andrada will vest on June 17, 2028, subject to certain terms and conditions.

What is the total number of DNUT shares beneficially owned by Marissa Andrada after the June 2025 transaction?

Following the transaction, Marissa Andrada beneficially owned a total of 67,947 shares, consisting of 4,140 direct shares and 63,807 unvested RSUs.

What was the purchase price of DNUT RSUs granted to Marissa Andrada?

The RSUs were granted to Marissa Andrada at a price of $0, as they were awarded as part of director compensation rather than purchased.

What position does Marissa Andrada hold at DNUT according to the Form 4?

According to the Form 4 filing, Marissa Andrada serves as a Director of Krispy Kreme, Inc. (DNUT).